Name

MDX-210

Alternate Names

None

Abbreviations

None

Category

Chemotherapy

Subcategory

Cytostatic agent--anti HER2

NSC Number

None

Primary Site

Breast
leukemia
ovarian cancer

Histology

None

Remarks

Phase II (breast) Phase II AML Phase II/III ovarian Monoclonal antibody. Medarex, IDM.

Coding

This drug should be coded
Glossary